PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23792568-4	2013	We report a case of a patient with BRAF-mutant metastatic colon cancer whose disease had progressed on FOLFOX plus bevacizumab and subsequent FOLFIRI plus cetuximab.	FOLFIRI regimen	142-149	B-Raf proto-oncogene, serine/threonine kinase	Homo sapiens	35-39